International Stem Cell Corporation’s Parkinson’s program was highlighted in this week’s San Diego Business Journal “BIOTECH: Stem Cell Therapy Would Repair Damaged Brain Tissue”.
We look forward to enrolling patients into our Parkinson’s disease clinical trial which we are expecting to begin as soon as we receive regulatory approval from Therapeutic Goods Administration.
You can read the full article (behind SDBJ's
pay-wall) here.
|